Supplemental material
OncoImmunology
Volume 8, 2019 - Issue 2
Open access
2,762
Views
21
CrossRef citations to date
0
Altmetric
Original Research
Bortezomib sensitizes multiple myeloma to NK cells via ER-stress-induced suppression of HLA-E and upregulation of DR5
Mattias CarlstenLaboratory of Transplantation Immunotherapy, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MDUSACorrespondence[email protected]
http://orcid.org/0000-0001-9815-0012View further author information
Ali NamaziLaboratory of Transplantation Immunotherapy, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MDUSAView further author information
, Robert RegerLaboratory of Transplantation Immunotherapy, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MDUSAView further author information
, Emily LevyLaboratory of Transplantation Immunotherapy, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MDUSAView further author information
, Maria BergLaboratory of Transplantation Immunotherapy, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MDUSAView further author information
, Cynthia St. HilaireLaboratory of Cardiovascular Regenerative Medicine, Center for Molecular Medicine, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MDUSA
http://orcid.org/0000-0003-1871-6915View further author information
Richard W. ChildsLaboratory of Transplantation Immunotherapy, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MDUSAView further author information
show all
Article: e1534664
|
Received 30 Apr 2018, Accepted 05 Oct 2018, Published online: 02 Nov 2018
Related Research Data
Implication of unfolded protein response in resveratrol-induced inhibition of K562 cell proliferation
Source:
Elsevier BV
Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress
Source:
Springer Science and Business Media LLC
Selenite Induces Posttranscriptional Blockade of HLA-E Expression and Sensitizes Tumor Cells to CD94/NKG2A-Positive NK Cells
Source:
The American Association of Immunologists
A Phase I Trial of Adoptively Transferred Ex-Vivo Expanded Autologous Natural Killer (NK) Cells Following Treatment with Bortezomib to Sensitize Tumors to NK Cell Cytotoxicity
Source:
American Society of Hematology
Bortezomib and Depsipeptide Sensitize Tumors to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand: A Novel Method to Potentiate Natural Killer Cell Tumor Cytotoxicity
Source:
American Association for Cancer Research (AACR)
NK cell education: not an on-off switch but a tunable rheostat
Source:
Elsevier BV
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Source:
American Society of Hematology
Functions of natural killer cells
Source:
Springer Science and Business Media LLC
Methylseleninic acid and sodium selenite induce severe ER stress and subsequent apoptosis through UPR activation in PEL cells.
Source:
Elsevier BV
Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium.
Source:
Springer Science and Business Media LLC
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Source:
Springer Science and Business Media LLC
Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.
Source:
The American Association of Immunologists
Acquisition of a multidrug-resistant phenotype with a proteasome inhibitor in multiple myeloma
Source:
Springer Science and Business Media LLC
Bringing natural killer cells to the clinic: ex vivo manipulation
Source:
American Society of Hematology
Analysis of human lymphocyte antigen class I expression in gastric cancer by reverse transcriptase-polymerase chain reaction.
Source:
Elsevier BV
Bortezomib down-regulates the cell surface expression of HLA-class I and enhances natural killer cell-mediated lysis of myeloma
Source:
American Society of Hematology
Expression and Release of HLA-E by Melanoma Cells and Melanocytes: Potential Impact on the Response of Cytotoxic Effector Cells
Source:
HAL CCSD
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.
Source:
American Society of Hematology
Sensitization of human breast cancer cells to natural killer cell-mediated cytotoxicity by proteasome inhibition.
Source:
Oxford University Press (OUP)
The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies
Source:
Springer Science and Business Media LLC
Proteasome inhibitor therapy in multiple myeloma
Source:
American Association for Cancer Research (AACR)
Inhibition of eIF2α Dephosphorylation Maximizes Bortezomib Efficiency and Eliminates Quiescent Multiple Myeloma Cells Surviving Proteasome Inhibitor Therapy
Source:
American Association for Cancer Research (AACR)
HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT
Source:
Springer Science and Business Media LLC
Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34 + blasts in myelodysplastic syndrome
Source:
Springer Science and Business Media LLC
Self-consumption: the interplay of autophagy and apoptosis
Source:
Springer Science and Business Media LLC
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.